ResMed
328 hedge funds and large institutions have $3.83B invested in ResMed in 2013 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 110 increasing their positions, 126 reducing their positions, and 37 closing their positions.
22% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 37
2% more funds holding
Funds holding: 322 → 328 (+6)
4.81% less ownership
Funds ownership: 62.69% → 57.88% (-4.8%)
13% less repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 126
15% less capital invested
Capital invested by funds: $4.52B → $3.83B (-$692M)
53% less call options, than puts
Call options by funds: $30.2M | Put options by funds: $63.8M
56% less funds holding in top 10
Funds holding in top 10: 9 → 4 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$53.1M |
| 2 |
Tiger Global Management
New York
|
+$50.6M |
| 3 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
+$31.3M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$28M |
| 5 |
HI
Honeywell International
Charlotte,
North Carolina
|
+$27.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$157M |
| 2 |
LCG
Luxor Capital Group
New York
|
-$117M |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$61M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$49.3M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$45.3M |
RMD Hedge Fund Activity: Q4 2013 in Review
328 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2013, worth a combined $3.83B — down 15% from $4.52B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new RMD positions and 37 closed out — a net gain of 8 holders — while 110 added to existing stakes and 126 trimmed.
The largest buyer was Citigroup, adding an estimated $53.1M. The largest seller was Invesco, cutting an estimated $157M.
- 328 institutional investors held ResMed (RMD) as of Q4 2013, up from 322 in Q3 2013.
- Funds reported $3.83B of ResMed stock for Q4 2013, down 15% quarter-over-quarter.
- 45 funds opened new ResMed positions in Q4 2013 and 37 closed out, a net change of +8 holders.
- The largest ResMed buyer in Q4 2013 was Citigroup, an estimated $53.1M added.
- The largest ResMed seller in Q4 2013 was Invesco, an estimated $157M sold.
Based on aggregated 13F filings for Q4 2013.